Reuters - Elan and Wyeth’s key new drug
bapineuzumab worked for a substantial proportion of Alzheimer’s
disease patients in an intermediate clinical trial, supporting
a prior decision to start final Phase III tests.
Independent honest reviews of most effective natural herbal supplements
Reuters - Elan and Wyeth’s key new drug
bapineuzumab worked for a substantial proportion of Alzheimer’s
disease patients in an intermediate clinical trial, supporting
a prior decision to start final Phase III tests.
The URI to TrackBack this entry is: http://herbal-review.com/2008/06/17/elan-wyeth-drug-helps-some-alzheimers-patients-reuters/trackback/
Please healthy :)
You must be logged in to post a comment.
|No results yet!
26 queries. 0.908 seconds